JP2003523364A5 - - Google Patents

Download PDF

Info

Publication number
JP2003523364A5
JP2003523364A5 JP2001561027A JP2001561027A JP2003523364A5 JP 2003523364 A5 JP2003523364 A5 JP 2003523364A5 JP 2001561027 A JP2001561027 A JP 2001561027A JP 2001561027 A JP2001561027 A JP 2001561027A JP 2003523364 A5 JP2003523364 A5 JP 2003523364A5
Authority
JP
Japan
Prior art keywords
mol
hydrogenation
isomer
hplc
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001561027A
Other languages
English (en)
Japanese (ja)
Other versions
JP4778181B2 (ja
JP2003523364A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/000523 external-priority patent/WO2001055175A2/en
Publication of JP2003523364A publication Critical patent/JP2003523364A/ja
Publication of JP2003523364A5 publication Critical patent/JP2003523364A5/ja
Application granted granted Critical
Publication of JP4778181B2 publication Critical patent/JP4778181B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001561027A 2000-01-28 2001-01-18 アセチル−アミジニオフェニルアラニル−シクロヘキシルグリシル−ピリジニオアラニンアミドの製造方法 Expired - Fee Related JP4778181B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10003586 2000-01-28
DE10003586.8 2000-01-28
PCT/EP2001/000523 WO2001055175A2 (en) 2000-01-28 2001-01-18 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides

Publications (3)

Publication Number Publication Date
JP2003523364A JP2003523364A (ja) 2003-08-05
JP2003523364A5 true JP2003523364A5 (cg-RX-API-DMAC7.html) 2008-02-28
JP4778181B2 JP4778181B2 (ja) 2011-09-21

Family

ID=7628946

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001561027A Expired - Fee Related JP4778181B2 (ja) 2000-01-28 2001-01-18 アセチル−アミジニオフェニルアラニル−シクロヘキシルグリシル−ピリジニオアラニンアミドの製造方法

Country Status (29)

Country Link
US (2) US20010031858A1 (cg-RX-API-DMAC7.html)
EP (1) EP1254159B9 (cg-RX-API-DMAC7.html)
JP (1) JP4778181B2 (cg-RX-API-DMAC7.html)
KR (1) KR100758141B1 (cg-RX-API-DMAC7.html)
CN (1) CN1176104C (cg-RX-API-DMAC7.html)
AR (1) AR027246A1 (cg-RX-API-DMAC7.html)
AT (1) ATE325810T1 (cg-RX-API-DMAC7.html)
AU (1) AU779722B2 (cg-RX-API-DMAC7.html)
BR (1) BR0107804A (cg-RX-API-DMAC7.html)
CA (1) CA2398497C (cg-RX-API-DMAC7.html)
CZ (1) CZ20022583A3 (cg-RX-API-DMAC7.html)
DE (1) DE60119491T2 (cg-RX-API-DMAC7.html)
DK (1) DK1254159T3 (cg-RX-API-DMAC7.html)
EE (1) EE200200410A (cg-RX-API-DMAC7.html)
ES (1) ES2262632T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20020631A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0301986A2 (cg-RX-API-DMAC7.html)
IL (2) IL150897A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02006762A (cg-RX-API-DMAC7.html)
NO (1) NO20023577L (cg-RX-API-DMAC7.html)
NZ (1) NZ520427A (cg-RX-API-DMAC7.html)
PL (1) PL356801A1 (cg-RX-API-DMAC7.html)
PT (1) PT1254159E (cg-RX-API-DMAC7.html)
RU (1) RU2250212C2 (cg-RX-API-DMAC7.html)
SK (1) SK10842002A3 (cg-RX-API-DMAC7.html)
TW (1) TWI236481B (cg-RX-API-DMAC7.html)
WO (1) WO2001055175A2 (cg-RX-API-DMAC7.html)
YU (1) YU51202A (cg-RX-API-DMAC7.html)
ZA (1) ZA200205990B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695999A5 (de) 2002-02-28 2006-11-15 Wilex Ag Verfahren zur Herstellung von 3- Amidinophenylalanin-Derivaten.
WO2007065691A2 (en) * 2005-12-07 2007-06-14 Technische Universität München Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins
CN101774942B (zh) * 2010-01-27 2012-08-22 宁波武盛化学有限公司 制备n-乙酰基-dl-环己基甘氨酸的方法
CN102984945B (zh) * 2010-04-20 2014-08-20 凯瑞斯德生化(苏州)有限公司 一种环烯基在β位取代的丙氨酸的不对称合成方法
JP5913352B2 (ja) * 2010-11-29 2016-04-27 高砂香料工業株式会社 不斉水素化触媒、およびそれを用いた光学活性カルボニル化合物の製造方法
CN115068469B (zh) * 2022-07-08 2024-02-27 深圳市小分子新药创新中心有限公司 Tigit抑制剂及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
US4623717A (en) 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4440679A (en) 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
DE69426897T2 (de) * 1993-10-15 2001-07-05 Rhone-Poulenc Rorer Pharmaceuticals, Inc. Antithrombotisch wirkende azacycloalkyl-alkanoyl-peptide und-pseudopeptide
US5849510A (en) 1994-04-26 1998-12-15 Selectide Corporation Factor Xa inhibitors
RU2152954C1 (ru) * 1994-04-26 2000-07-20 Селектид Корпорейшн Ингибиторы фактора ха
RU2170764C2 (ru) * 1995-12-20 2001-07-20 Авентис Фармасьютикалз Инк. НОВЫЙ СПОСОБ ПОЛУЧЕНИЯ N-АЦЕТИЛ-(L)-4-ЦИАНОФЕНИЛАЛАНИНА АС-(L)-PHE(4-CN)-OH И N-АЦЕТИЛ-(L)-N-АМИДИНОФЕНИЛАЛАНИН-ЦИКЛОГЕКСИЛ-ГЛИЦИН-β-(3-N-МЕТИЛПИРИДИН ИЯ)-АЛАНИНА АС-(L)-PАPH-СHG-РAL МE(3)-NH2
DE19856443A1 (de) 1998-12-08 2000-06-21 Centeon Pharma Gmbh Stabilisiertes Antithrombin III-Präparat

Similar Documents

Publication Publication Date Title
TWI225476B (en) Novel process of preparing tolterodine and analogues thereof, and novel intermediates prepared therein
HK1079790A1 (zh) 10,11-二氢-10-羟基-5h-二苯并b,f氮杂卓-5-羧酰胺的对映体及其新晶形两者制备的对映选择性方法
CA2450093A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
MXPA03011972A (es) Arilaminas para tratamiento de condiciones asociadas con gsk-3.
JP2005500987A5 (cg-RX-API-DMAC7.html)
JP2006521826A5 (cg-RX-API-DMAC7.html)
SI8310672A8 (en) Process for the production of cis-4-fenil-1,2,3,4-tetrahydro-1-naphthylamine derivates.
MXPA04000756A (es) Nuevos compuestos.
WO2002065979A3 (en) (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
JP2003523364A5 (cg-RX-API-DMAC7.html)
WO2004060277A3 (en) Process for purification of plasmid dna
JP2004532624A5 (cg-RX-API-DMAC7.html)
WO2004063185A8 (en) Thiophene carboxamides as inhibitors of the enzyme ikk-2
WO2005014608A3 (en) Process for preparing maltitol enriched products
TR200503401T1 (tr) Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları
WO2003048082A3 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
SI1170281T1 (sl) Nove spojine 1,1-in 1,2-disubstituirani ciklopropani, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
NO20042681L (no) Ny krystallinsk polymorf av venlafaxine-hydroklorid og fremgangsmater for fremstilling derav
JP2000351758A (ja) キラルテトラロンからのセルトラリンの製造法
NO20061310L (no) Nye forbindelser og deres anvendelse i medisin; fremgangsmate for deres fremstilling og farmasoytiske sammensetninger som inneholder dem
WO2006035433A3 (en) Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride
WO2005023791A3 (en) Process for the production of mycophenolate mofetil
PL372933A1 (en) Methylthiophene carboxanilides
CA2534194A1 (en) Indoline-sulfanilic acid amides used as ppar delta modulators
NO20061404L (no) Renseprosess